Swapan Majumdar
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Swapan Majumdar has a total of 53 co-authors. Here are the top co-authors by number of shared publications:
Bhaswati Paul
CSIR-Indian Institute of Chemical Biology, 4, Raja S. C. Mullick Road, Jadavpur, Kolkata-700032, INDIA
6 shared publications- Barnali Das
Department of Chemistry, Tripura University, Suryamaninagar, 799 022, India
4 shared publications Abhijit Rudra Paul
Department of Chemistry Tripura University Suryamaninagar 799 022 Tripura India
3 shared publications- Arghyadeep Bhattacharyya
Department of Chemistry Tripura University Suryamaninagar India
3 shared publications - Hussain Sanfui
Advanced Polymer Laboratory, Department of Polymer Science and Technology, Government College of Engineering and Leather Technology (Post Graduate), Maulana Abul Kalam Azad University of Technology, Salt Lake City, Kolkata 700106, West Bengal, India
3 shared publications - Kamal Das
Department of Chemistry, Tripura University, Suryamaninagar, 799 022, India
3 shared publications
Latest Publications
- 1 February 2026
- Published by Bentham Science Publishers Ltd. in Current Organocatalysis
- Vol. 13 (1) , 2-29
Exploring the Role of Benzimidazole-Containing Scaffolds for the Design of New Compounds in Drug Discovery
Introduction: Benzimidazole and its derivatives are among the most popular structures used in pharmaceutical and medicinal chemistry for drug discovery, particularly within the wide variety of heterocycles. Benzimidazole has a preferred structure in drug discovery due to its distinct structural characteristics and the diverse biological actions of its derivatives. Methods: This study highlights the significance of this moiety due to its broad range of biological features and the widespread use of benzimidazole. Results: This review consolidates extensive research conducted from 1990 to 2025, highlighting benzimidazole derivatives as key pharmacophores across diverse therapeutic areas. Benzimidazole compounds exhibit multifaceted anti-inflammatory, analgesic, antiviral, anticancer, antioxidant, and anthelmintic activities, indicating their systemic benefits. Discussion: In many drugs used to treat conditions such as cancer, microbial infections, inflamma-tory disorders, hypertension, and malaria, the benzimidazole ring structure exhibits a broad range of pharmacological activity. Additionally, this fused heterocycle benzimidazole core may interact with various anions and cations, as well as biomolecules, in the human body to produce a range of biological activities, including antidepressant, antiviral, antibacterial, antifungal, anti-inflamma-tory, and analgesic effects. Conclusion: This review focuses on benzimidazole derivatives and their effects on different sites of action, as well as contemporary developments in drug design and development.
- 1 February 2026
- Published by Bentham Science Publishers Ltd. in Current Organocatalysis
- Vol. 13 (1) , 2-29
Exploring the Role of Benzimidazole-Containing Scaffolds for the Design of New Compounds in Drug Discovery
Introduction: Benzimidazole and its derivatives are among the most popular structures used in pharmaceutical and medicinal chemistry for drug discovery, particularly within the wide variety of heterocycles. Benzimidazole has a preferred structure in drug discovery due to its distinct structural characteristics and the diverse biological actions of its derivatives. Methods: This study highlights the significance of this moiety due to its broad range of biological features and the widespread use of benzimidazole. Results: This review consolidates extensive research conducted from 1990 to 2025, highlighting benzimidazole derivatives as key pharmacophores across diverse therapeutic areas. Benzimidazole compounds exhibit multifaceted anti-inflammatory, analgesic, antiviral, anticancer, antioxidant, and anthelmintic activities, indicating their systemic benefits. Discussion: In many drugs used to treat conditions such as cancer, microbial infections, inflamma-tory disorders, hypertension, and malaria, the benzimidazole ring structure exhibits a broad range of pharmacological activity. Additionally, this fused heterocycle benzimidazole core may interact with various anions and cations, as well as biomolecules, in the human body to produce a range of biological activities, including antidepressant, antiviral, antibacterial, antifungal, anti-inflamma-tory, and analgesic effects. Conclusion: This review focuses on benzimidazole derivatives and their effects on different sites of action, as well as contemporary developments in drug design and development.
- Open Access
- 1 January 2026
- Published by Royal Society of Chemistry (RSC) in RSC Advances
Push–pull luminescent imidazole derivatives: ICT enables efficient picric acid sensing
Synthesized ICT-active probes 3a and 3b detect picric acid. The electron-releasing methoxy groups in 3b enhance the ICT characteristics as well as the sensitivity towards picric acid.
- 1 January 2026
- Published by Royal Society of Chemistry (RSC) in RSC Advances
Open AccessPush–pull luminescent imidazole derivatives: ICT enables efficient picric acid sensing
Synthesized ICT-active probes 3a and 3b detect picric acid. The electron-releasing methoxy groups in 3b enhance the ICT characteristics as well as the sensitivity towards picric acid.
- Open Access
- 8 October 2025
- Published by Royal Society of Chemistry (RSC) in RSC Advances
- Vol. 15 (45) , 37888-37898
Metal-free access to 4-indolyl coumarin from coumarin 3-carboxylic acid and indole via a Michael addition-decarboxylation and dehydrogenation protocol: a photo-physical study and utility as an invisible ink
Here, two-step synthesis of coumarin-indole hybrids from coumarin 3-carboxylic acid and indole is reported. The photo-physical properties of the synthesized hybrids and their possible use as invisible ink are also investigated.
- 8 October 2025
- Published by Royal Society of Chemistry (RSC) in RSC Advances
- Vol. 15 (45) , 37888-37898
Open AccessMetal-free access to 4-indolyl coumarin from coumarin 3-carboxylic acid and indole via a Michael addition-decarboxylation and dehydrogenation protocol: a photo-physical study and utility as an invisible ink
Here, two-step synthesis of coumarin-indole hybrids from coumarin 3-carboxylic acid and indole is reported. The photo-physical properties of the synthesized hybrids and their possible use as invisible ink are also investigated.
- Open Access
- 13 February 2025
- Published by Royal Society of Chemistry (RSC) in RSC Advances
- Vol. 15 (7) , 5523-5534
FeCl3/SiO2-catalyzed bis-indolylation of acetals and ketals: a highly atom-economical approach to the selective deprotection of protected carbohydrates
Herein, we report a general and green protocol for FeCl3/SiO2-catalyzed bis-indolylation of acetals and ketals, which is extended to a 100% atom-economical approach for the deprotection of protected carbohydrates.
- 13 February 2025
- Published by Royal Society of Chemistry (RSC) in RSC Advances
- Vol. 15 (7) , 5523-5534
Open AccessFeCl3/SiO2-catalyzed bis-indolylation of acetals and ketals: a highly atom-economical approach to the selective deprotection of protected carbohydrates
Herein, we report a general and green protocol for FeCl3/SiO2-catalyzed bis-indolylation of acetals and ketals, which is extended to a 100% atom-economical approach for the deprotection of protected carbohydrates.
- Open Access
- 17 October 2024
- Published by Royal Society of Chemistry (RSC) in RSC Advances
- Vol. 14 (45) , 33512-33523
An elegant approach for the synthesis of multisubstituted imidazole via FeCl3/SiO2 catalyzed activation of acetals: a photophysical study of an imidazole–carbazole hybrid
Here, synthesis of substituted imidazoles from benzil, protected carbonyl and NH4OAc/primary amine in the presence of a FeCl3/SiO2 catalyst is reported. The photophysical property of the synthesized imidazole–carbazole hybrid is also investigated.
- 17 October 2024
- Published by Royal Society of Chemistry (RSC) in RSC Advances
- Vol. 14 (45) , 33512-33523
Open AccessAn elegant approach for the synthesis of multisubstituted imidazole via FeCl3/SiO2 catalyzed activation of acetals: a photophysical study of an imidazole–carbazole hybrid
Here, synthesis of substituted imidazoles from benzil, protected carbonyl and NH4OAc/primary amine in the presence of a FeCl3/SiO2 catalyst is reported. The photophysical property of the synthesized imidazole–carbazole hybrid is also investigated.
- Open Access
- 24 March 2024
- Published by Wiley in Cancer Reports
- Vol. 7 (3) , e2049
Epidermal growth factor receptor inhibition potentiates chemotherapeutics‐mediated sensitization of metastatic breast cancer stem cells
Background: Metastasis has been a cause of the poor prognosis and cancer relapse of triple‐negative breast cancer (TNBC) patients. The metastatic nature of TNBC is contributed by the breast cancer stem cells (CSCs) which have been implicated in tumorigenesis. Higher expression of epidermal growth factor receptor (EGFR) in breast CSCs has been used as a molecular target for breast cancer therapeutics. Thus, it necessitates the design and generation of efficacious EGFR inhibitors to target the downstream signaling associated with the cellular proliferation and tumorigenesis of breast cancer.Aim: To generate efficacious EGFR inhibitors that can potentiate the chemotherapeutic‐mediated mitigation of breast cancer tumorigenesis.Methods and Results: We identified small molecule EGFR inhibitors using molecular docking studies. In‐vitro screening of the compounds was undertaken to identify the cytotoxicity profile of the small‐molecule EGFR inhibitors followed by evaluation of the non‐cytotoxic compounds in modulating the doxorubicin‐induced migration, in‐vitro tumorigenesis potential, and their effect on the pro‐apoptotic genes' and protein markers' expression in TNBC cells. Compound 1e potentiated the doxorubicin‐mediated inhibitory effect on proliferation, migration, in‐vitro tumorigenesis capacity, and induction of apoptosis in MDA‐MB‐231 cells, and in the sorted CD24+‐breast cancer cells and CD24−/CD44+‐breast CSC populations. Orthotopic xenotransplantation of the breast CSCs‐induced tumors in C57BL/6J mice was significantly inhibited by the low dose of Doxorubicin in the presence of compound 1e as depicted by molecular and immunohistochemical analysis.Conclusion: Thus, the study suggests that EGFR inhibition‐mediated sensitization of the aggressive and metastatic breast CSCs in TNBCs toward chemotherapeutics may reduce the relapse of the disease.
- 24 March 2024
- Published by Wiley in Cancer Reports
- Vol. 7 (3) , e2049
Open AccessEpidermal growth factor receptor inhibition potentiates chemotherapeutics‐mediated sensitization of metastatic breast cancer stem cells
Background: Metastasis has been a cause of the poor prognosis and cancer relapse of triple‐negative breast cancer (TNBC) patients. The metastatic nature of TNBC is contributed by the breast cancer stem cells (CSCs) which have been implicated in tumorigenesis. Higher expression of epidermal growth factor receptor (EGFR) in breast CSCs has been used as a molecular target for breast cancer therapeutics. Thus, it necessitates the design and generation of efficacious EGFR inhibitors to target the downstream signaling associated with the cellular proliferation and tumorigenesis of breast cancer.Aim: To generate efficacious EGFR inhibitors that can potentiate the chemotherapeutic‐mediated mitigation of breast cancer tumorigenesis.Methods and Results: We identified small molecule EGFR inhibitors using molecular docking studies. In‐vitro screening of the compounds was undertaken to identify the cytotoxicity profile of the small‐molecule EGFR inhibitors followed by evaluation of the non‐cytotoxic compounds in modulating the doxorubicin‐induced migration, in‐vitro tumorigenesis potential, and their effect on the pro‐apoptotic genes' and protein markers' expression in TNBC cells. Compound 1e potentiated the doxorubicin‐mediated inhibitory effect on proliferation, migration, in‐vitro tumorigenesis capacity, and induction of apoptosis in MDA‐MB‐231 cells, and in the sorted CD24+‐breast cancer cells and CD24−/CD44+‐breast CSC populations. Orthotopic xenotransplantation of the breast CSCs‐induced tumors in C57BL/6J mice was significantly inhibited by the low dose of Doxorubicin in the presence of compound 1e as depicted by molecular and immunohistochemical analysis.Conclusion: Thus, the study suggests that EGFR inhibition‐mediated sensitization of the aggressive and metastatic breast CSCs in TNBCs toward chemotherapeutics may reduce the relapse of the disease.
- 15 December 2023
- Published by Wiley in ChemistrySelect
- Vol. 8 (47)
Unsymmetrical Bis‐Coumarin Based on o‐Hydroxy Aldehydes and 4‐Hydroxy Coumarin: Expedient Synthesis, Single Crystal X‐rays and DFT Studies
Bis‐coumarins are distinguished derivatives of coumarin which bear numerous pharmaceutical and other applications. In continuation of our ongoing research towards the development of benign protocols for various heterocyclic systems, herein we report an Amberlyst 15 mediated synthesis of unsymmetrical bis‐coumarins via in situ generation and cyclization of symmetrical bis‐coumarinyl methanes derived from o‐hydroxy aromatic aldehydes and 4‐hydroxy coumarin. Aldehydes of both electron‐donating and electron‐withdrawing units underwent smooth conversion to their respective unsymmetrical bis‐coumarins (76–98 % yield) without leaving any side products or intermediates. The catalyst used in the present protocol is cost‐effective, eco‐friendly, and readily available which could be recovered and reused several times. This methodology offers operational simplicity, low catalyst loading, and avoids the use of toxic solvents/reagents and the product can be isolated without chromatography. DFT study indicated that the driving force for the cyclisation of symmetrical bis‐coumarin is the minimization of the tetrahedral bond angle deviations along with other small non‐covalent interactions. Some DFT data was also verified with the data obtained from the X‐rays crystallographic study.
- 15 December 2023
- Published by Wiley in ChemistrySelect
- Vol. 8 (47)
Unsymmetrical Bis‐Coumarin Based on o‐Hydroxy Aldehydes and 4‐Hydroxy Coumarin: Expedient Synthesis, Single Crystal X‐rays and DFT Studies
Bis‐coumarins are distinguished derivatives of coumarin which bear numerous pharmaceutical and other applications. In continuation of our ongoing research towards the development of benign protocols for various heterocyclic systems, herein we report an Amberlyst 15 mediated synthesis of unsymmetrical bis‐coumarins via in situ generation and cyclization of symmetrical bis‐coumarinyl methanes derived from o‐hydroxy aromatic aldehydes and 4‐hydroxy coumarin. Aldehydes of both electron‐donating and electron‐withdrawing units underwent smooth conversion to their respective unsymmetrical bis‐coumarins (76–98 % yield) without leaving any side products or intermediates. The catalyst used in the present protocol is cost‐effective, eco‐friendly, and readily available which could be recovered and reused several times. This methodology offers operational simplicity, low catalyst loading, and avoids the use of toxic solvents/reagents and the product can be isolated without chromatography. DFT study indicated that the driving force for the cyclisation of symmetrical bis‐coumarin is the minimization of the tetrahedral bond angle deviations along with other small non‐covalent interactions. Some DFT data was also verified with the data obtained from the X‐rays crystallographic study.
- 10 October 2023
- Published by Springer Nature in Silicon
- Vol. 16 (2) , 967-977
H-Bond Driven Solvent-Free Rapid Access of β-enamino Esters/Ketones using 230-400 Mesh Silica Gel as a Catalyst
- 10 October 2023
- Published by Springer Nature in Silicon
- Vol. 16 (2) , 967-977
H-Bond Driven Solvent-Free Rapid Access of β-enamino Esters/Ketones using 230-400 Mesh Silica Gel as a Catalyst
- 28 September 2023
- Published by American Chemical Society (ACS) in ACS Applied Nano Materials
- Vol. 6 (19) , 17952-17971
Excited-State Energy Transfer-Associated Dual Emission of Light-Emitting Polymers Containing Sulfonated Graphene Oxide for Sensing of pH, Co(II), and Bi(III)
- 28 September 2023
- Published by American Chemical Society (ACS) in ACS Applied Nano Materials
- Vol. 6 (19) , 17952-17971
Excited-State Energy Transfer-Associated Dual Emission of Light-Emitting Polymers Containing Sulfonated Graphene Oxide for Sensing of pH, Co(II), and Bi(III)